CNSX:KBB

Kaneh Bosm Biotechnology (KBB) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.33 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Kaneh Bosm Biotechnology

Kaneh Bosm Biotechnology Inc., formerly Anexco Resources Ltd., operates in the cannabis sector. The Company focuses on the deployment of kiosks to ultimate retail locations, and is evaluating various gold and lithium mining assets for potential acquisition. The Company is focused on identifying, acquiring and developing projects with a focus on precious metals deposits. The Company entered into a purchase agreement with Alps Innovations Group Inc. for North and South American rights to an intelligent automated retail kiosk, the BioCanna ADM Automated Cannabis retail system, for the dispensing of cannabis and related products in both medical and commercial markets (the Agreement). BioCanna ADM system is an automated dispensing machine, which is a hybrid between a bank automatic teller machine (ATM), and an intelligent retail kiosk. It operates its engineering, procurement and construction (EPC) division, a full-service engineering, procurement and construction service.

KBB Stock News Headlines

Uncover this 2024 Hidden Gem
Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.
NASDAQ Biotechnology (^NBI)
See More Headlines
Receive KBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kaneh Bosm Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Michael Martinz
    President, Director
  • Rudy de Jonge
    Chief Executive Officer, Director
  • Anthony Jackson (Age 34)
    Chief Financial Officer
  • Kent Ausburn Ph.D.
    Chief Operating Officer, Director
  • Matthew Wyatt Lechtzier (Age 53)
    Director

KBB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Kaneh Bosm Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kaneh Bosm Biotechnology investors own include Jubilee Metals Group (JLP), 156478 (DDD.L) (DDD), Clontarf Energy (CLON) and ADVFN (AFN).

How do I buy shares of Kaneh Bosm Biotechnology?

Shares of KBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:KBB) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners